Sign in Create account

EIKO LIFESCIENCES LIMITED

Chemicals · Chemicals & Petrochemicals

BSE: 540204
₹49.76
▼ -1.93 (-3.73%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
61/100
Moderate
Valuation
90/100
Undervalued
Momentum
68/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹71 Cr
PE (TTM)
17.6
Industry median 24.4 (189 companies)
Price to Book
1.0
PEG (TTM)
0.2
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-20.5
Free Cash Flow
₹2 Cr
as of March 31, 2026
Industry median ₹-0 Cr (238 companies)
EPS Growth (YoY)
48.00%
as of June 30, 2026
Industry median 39.08% (220 companies)
Net Profit Growth (TTM)
81.26%
as of June 30, 2026
Industry median 13.45% (212 companies)
Operating Revenue Growth (TTM)
67.34%
as of June 30, 2026
Industry median 7.93% (209 companies)
Profit Growth (YoY)
53.76%
as of June 30, 2026
Industry median 23.11% (213 companies)
Revenue Growth (YoY)
90.26%
as of June 30, 2026
Industry median 17.49% (205 companies)
Current Ratio
3.08
as of March 31, 2026
Industry median 1.87 (237 companies)
Debt to Equity
0.07
as of March 31, 2026
Industry median 0.16 (224 companies)
Interest Coverage
29.11
as of June 30, 2026
Industry median 8.97 (221 companies)
Net Margin
7.50%
as of June 30, 2026
Industry median 7.49% (212 companies)
Operating Margin (EBIT)
10.19%
as of June 30, 2026
Industry median 11.88% (214 companies)
Operating Margin (TTM)
11.04%
as of June 30, 2026
Industry median 9.75% (219 companies)
Return on Assets
3.63%
as of March 31, 2026
Industry median 4.33% (217 companies)
Return on Capital Employed
7.14%
as of March 31, 2026
Industry median 10.34% (218 companies)
Return on Equity
4.45%
as of March 31, 2026
Industry median 7.52% (219 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 6 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.07)
  • No Return on equity is 15% or more (4.4%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-3.7%
Low 49.7500 · High 52.9000
1W return
1.2%
Low 47.0600 · High 53.6900
1M return
5.5%
Low 43.0000 · High 53.6900
52W return
-22.6%
Low 43.0000 · High 53.6900
Lifetime High ₹105.0000 (Aug. 9, 2021)
Lifetime Low ₹7.6600 (April 20, 2020)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish3
Bearish3
5D
50.4
10D
49.2
20D
48.2
50D
48.6
100D
50.8
200D
56.2

Delivery and volume

Day avg. delivery
92.5%
Week avg. delivery
84.1%
Month avg. delivery
81.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

50.80
Pivot
First resistance51.86
Second resistance53.95
Third resistance55.01
First support48.71
Second support47.65
Third support45.56
Day RSI55.4
Day MFI58.9
Day MACD0.82
Day MACD signal0.04

Beta

1M-0.96
3M-0.53
1Y-0.53
3Y0.31

Price change analysis

↑ 5.5%
Over 1 Month
LowHigh
43.0053.69
↓ -22.6%
Over 3 Months
LowHigh
43.0053.69
↓ -22.6%
Over 6 Months
LowHigh
43.0053.69
↓ -22.6%
Over 1 Year
LowHigh
43.0053.69
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 17.6 (own history: 22.7–70.1)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹14 Cr
Net profit (June 30, 2026)
₹1 Cr
Basic EPS (June 30, 2026)
₹0.7400

Ranks #162 of 221 in Chemicals & Petrochemicals by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter39.91%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 39.91% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 86 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
25 Jun 2025 SIDDHANT LAXMIKANT KABRA Bulk Buy 71,000 49.0600 BSE
27 Mar 2025 SIDDHANT LAXMIKANT KABRA Bulk Buy 130,000 51.6500 BSE
27 Mar 2025 2B BLACK BIO LLP Bulk Sell 137,000 51.6700 BSE
18 Feb 2025 2B BLACK BIO LLP Bulk Sell 68,199 50.7000 BSE
18 Feb 2025 SIDDHANT LAXMIKANT KABRA Bulk Buy 73,000 50.7300 BSE
11 Jul 2024 JOYANTAKUMARJANA Bulk Buy 83,350 67.4900 BSE
11 Jul 2024 ARITRO ASHISH ROY Bulk Sell 152,550 66.8500 BSE
10 Jul 2024 SAURABHTRIPATHI Bulk Buy 80,000 59.7700 BSE
5 Jul 2024 ARITRO ASHISH ROY Bulk Sell 107,415 51.0000 BSE
6 Jun 2024 SUREKH GUPTA HUF Bulk Buy 70,100 49.0000 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from NARENDRA INVESTMENTS (DELHI) LIMITED to EIKO LIFESCIENCES LIMITED

All corporate actions →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.07)
  • Comfortable interest coverage (29.1x)
  • Strong revenue growth YoY (90.3%)

Weaknesses

  • Low Return on Equity (4.4%)

Opportunities

  • PEG below 1 (0.23) -- earnings growth outpacing its own valuation

Threats

  • Down 22.6% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about EIKO LIFESCIENCES LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.